“…Improving gene editing, labeling RNA and other technologies ( Soekmadji et al, 2018 ), and exploring the cargo sorting mechanism to determine whether the effect of exosomes is related to the carrying of specific molecules. So, it is necessary to discover the key components of exosome therapy that cause therapeutic effects or side effects, to determine the dose, durability and experimental “control” of exosome therapy ( Tzng et al, 2023 ), and to optimize engineering and physicochemical techniques (e.g., molecular methods such as gene overexpression and mechanical methods such as supramagnetic paramagnetic nanoparticles) to improve the effective tumor targeting of exosomes ( Mardi et al, 2023 ), further clinical researches are needed to verify and promote the clinical transformation of exosomes. Then the development of new technologies (gene co-expression, overexpression of mRNA) or optimization technology (such as magnetization of metal oxide, membrane separation, microfluidic, immunoaffinity chromatography) ( Xiang et al, 2021 ; Chen et al, 2022 ) and further basic research, to produce exosomes with controllable quality on a large scale and promote the industrialization of exosome production (scale, purity, consistency, and standardization), improving the short half-life of exosome, zeta potential difference and other internal problems, and continue to expand the application of exosomes ( Chen et al, 2022 ).…”